Clinical Trial Update: Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating biomarkers (biosignatures) of response to cannabis oil in individuals with fibromyalgia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Cannabis oil (cannabis oil)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Fibromyalgia | Phase 2 | Status: RECRUITING